351 related articles for article (PubMed ID: 27144061)
1. Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification.
Kansal R
Cancer Biol Med; 2016 Mar; 13(1):41-54. PubMed ID: 27144061
[TBL] [Abstract][Full Text] [Related]
2. Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?
Madanat YF; Kalaycio ME; Nazha A
Acta Med Acad; 2019 Apr; 48(1):35-44. PubMed ID: 31264431
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukaemia: How to combine multiple tools.
Merino A; Boldú L; Ermens A
Int J Lab Hematol; 2018 May; 40 Suppl 1():109-119. PubMed ID: 29741260
[TBL] [Abstract][Full Text] [Related]
4. Classification of acute myeloid leukemia by the revised fourth edition World Health Organization criteria: a retrospective single-institution study with appraisal of the new entities of acute myeloid leukemia with gene mutations in NPM1 and biallelic CEBPA.
Kansal R
Hum Pathol; 2019 Aug; 90():80-96. PubMed ID: 31077683
[TBL] [Abstract][Full Text] [Related]
5. Current status and trends in the diagnostics of AML and MDS.
Shumilov E; Flach J; Kohlmann A; Banz Y; Bonadies N; Fiedler M; Pabst T; Bacher U
Blood Rev; 2018 Nov; 32(6):508-519. PubMed ID: 29728319
[TBL] [Abstract][Full Text] [Related]
6. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
[TBL] [Abstract][Full Text] [Related]
7. Mutational profiling of acute myeloid leukemia with normal cytogenetics in Brazilian patients: the value of next-generation sequencing for genomic classification.
de Noronha TR; Mitne-Neto M; Chauffaille ML
J Investig Med; 2017 Dec; 65(8):1155-1158. PubMed ID: 28923882
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic work-up of acute myeloid leukemia.
Weinberg OK; Sohani AR; Bhargava P; Nardi V
Am J Hematol; 2017 Mar; 92(3):317-321. PubMed ID: 28066929
[TBL] [Abstract][Full Text] [Related]
9. Mutational landscape of AML with normal cytogenetics: biological and clinical implications.
Martelli MP; Sportoletti P; Tiacci E; Martelli MF; Falini B
Blood Rev; 2013 Jan; 27(1):13-22. PubMed ID: 23261068
[TBL] [Abstract][Full Text] [Related]
10. Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia.
Wang BH; Li YH; Yu L
Chin Med J (Engl); 2015 Sep; 128(17):2395-403. PubMed ID: 26315090
[TBL] [Abstract][Full Text] [Related]
11. Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.
Falini B; Martelli MP
Best Pract Res Clin Haematol; 2015; 28(2-3):90-7. PubMed ID: 26590764
[TBL] [Abstract][Full Text] [Related]
12. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
[TBL] [Abstract][Full Text] [Related]
13. Acute Myeloid Leukemia With Recurrent Cytogenetic Abnormalities.
Foucar K; Anastasi J
Am J Clin Pathol; 2015 Jul; 144(1):6-18. PubMed ID: 26071458
[TBL] [Abstract][Full Text] [Related]
14. [Precision medicine for acute myeloid leukemia based on genomic profiling].
Sanada M
Rinsho Ketsueki; 2019; 60(7):847-853. PubMed ID: 31391376
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in precision medicine for acute myeloid leukemia.
Hernández-Sánchez A; Bullinger L
Curr Opin Oncol; 2023 Nov; 35(6):581-588. PubMed ID: 37621173
[TBL] [Abstract][Full Text] [Related]
16. Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach.
Suguna E; Farhana R; Kanimozhi E; Kumar PS; Kumaramanickavel G; Kumar CS
Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):199-207. PubMed ID: 29766829
[TBL] [Abstract][Full Text] [Related]
17. Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies.
Hou HA; Tien HF
J Biomed Sci; 2020 Jul; 27(1):81. PubMed ID: 32690020
[TBL] [Abstract][Full Text] [Related]
18. [Advances of study on prognostic factors of molecular biology in acute myeloid leukemia with normal cytogenetics].
Han TJ; Xu XP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1063-8. PubMed ID: 20723330
[TBL] [Abstract][Full Text] [Related]
19. The challenge of risk stratification in acute myeloid leukemia with normal karyotype.
Zaidi SZ; Owaidah T; Al Sharif F; Ahmed SY; Chaudhri N; Aljurf M
Hematol Oncol Stem Cell Ther; 2008; 1(3):141-58. PubMed ID: 20063545
[TBL] [Abstract][Full Text] [Related]
20. Genetic Characterization and Risk Stratification of Acute Myeloid Leukemia.
Pourrajab F; Zare-Khormizi MR; Hashemi AS; Hekmatimoghaddam S
Cancer Manag Res; 2020; 12():2231-2253. PubMed ID: 32273762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
